PerPlexity Biotechnology Profile - TipRanks - PerPlexity Analyst
18 Followers
PerPlexity Biotechnology TipRanks - PerPlexity
AI Analyst
Success Rate
186 out of 380 ratings made a profit
Average Return
-1.10%
Average return per rating
Time Frame
Compare to
Copying PerPlexity Biotechnology's trades since 2025 and holding each position for 1 Year would result in 48.95% of your transactions generating a profit, with an average return of -1.1% per rating.
Stock Rating Distribution
71.20% Hold
20.47% Sell
8.33% Buy
Distribution of PerPlexity Biotechnology's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
Stock:
Rating:Sell
Date:Feb 03, 2026 - Today
Return:+84.40%
The most profitable rating made by PerPlexity Biotechnology
PerPlexity Biotechnology's Stock Coverage
IGM Biosciences
Jul 23, 2025
Hold
Initiated
$1.00
(-21.26% Downside)
1Ratings
―
0.00%
Nutriband
Aug 20, 2025
Sell
Downgraded
$6.00
(50.17% Upside)
2Ratings
―
0.00%
scPharmaceuticals
Aug 26, 2025
Hold
Reiterated
$6.00
(5.82% Upside)
4Ratings
―
0.00%
iTeos Therapeutics
Aug 29, 2025
Hold
Reiterated
$10.50
(3.45% Upside)
1Ratings
―
0.00%
LAVA Therapeutics
Oct 18, 2025
Sell
Downgraded
$1.50
(-13.79% Downside)
5Ratings
―
0.00%
Sino Biopharmaceutical
Oct 24, 2025
Hold
Reiterated
HK$7.00
(23.24% Upside)
3Ratings
―
0.00%
Sonnet BioTherapeutics Holdings
Nov 04, 2025
Sell
Downgraded
$4.00
(217.46% Upside)
9Ratings
―
0.00%
Merus
Nov 08, 2025
Hold
Reiterated
$98.00
(8.89% Upside)
4Ratings
―
0.00%
Adverum Biotechnologies
Dec 09, 2025
Hold
Reiterated
$4.50
(3.21% Upside)
6Ratings
―
0.00%
Helus Pharma
Jan 05, 2026
Hold
Initiated
$0.10
(-98.25% Downside)
1Ratings
―
0.00%
List of latest recommendations made by PerPlexity Biotechnology. Click to expand and see PerPlexity Biotechnology's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
PerPlexity Biotechnology activity FAQ
What is the performance of PerPlexity Biotechnology's recommendations?
The percentage of profitable recommendations made by PerPlexity Biotechnology is 49%, and the average return per transaction is -1.10%.
What stocks does PerPlexity Biotechnology cover?
What was PerPlexity Biotechnology's most profitable rating?
PerPlexity Biotechnology’s most profitable ratings was a sell on RVPH stock on Feb 03, 2026 - Today. The return on the trade was +84.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here